Gene Query: PDLIM5

Dataset Description Geneva Score
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 103.87
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 91.15
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 91.15
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 87.54
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 67.59
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 67.59
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 64.48
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 62.82
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 54.43
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 54.43
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 53.18
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 49.83
Gene Expression Profiling of WT and KDM3A Knocked out Cell 49.75
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 49.75
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 46.99
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 44.74
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 44.74
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 43.63
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 42.69
Differential analysis of gene regulation at transcript resolution by RNA-Seq 42.69
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 41.79
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 41.33
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 40.48
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 40.15
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 39.55
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 37.05
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 34.8
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 34.8
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 33.22
STRIPAK directs PP2A activity to promote oncogenic transformation 33.19
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 33.12
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 32.78
METTL3 promotes translation in human cancer cells 32.69
LNCaP treated with iBET 32.29
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 32.28
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 32.1
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 32.1
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 32.04
The regulartory role of ZCCHC24 in splicing machinery 31.89
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 31.1
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 31.1
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 30.92
Global expression profiles in cardiac progenitor cells generated by ISX-9 30.92
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 29.63
Expression level comparison under dividing and quiescent states in human primary fibroblasts 29.44
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 29.37
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 29.19
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 29.18
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 29.17
SUV420H2 knockdown in PANC-1 28.96
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 28.79
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 28.72
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 27.75
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 27.21
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 26.98
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 26.9
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 26.55
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 26.5
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 26.41
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 26.17
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 25.97
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 25.72
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 24.93
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 24.77
RNA-seq of shEZH2 cells 24.14
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 24.1
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 23.83
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 23.71
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 23.7
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 23.7
A role for ZNF598 in post-transcriptional gene regulation 23.65
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 23.15
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 22.68
Gene expression analysis of the impact of TDP-43 knockout in human cells. 22.49
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 22.19
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 22.05
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 21.92
G-quadruplex structures mark human regulatory chromatin 21.45
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 21.31
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 21.29
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 21.29
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 21.06
Recovery and analysis of nascent RNA 20.67
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 20.67
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 20.61
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 20.56
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 20.44
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 20.44
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 20.19
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 20.14
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 20.13
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 20.13
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 20.08
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 20.04
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 19.99
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 19.99
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 19.7
Epigenomic landscape during organ formation in human early embryos 19.65
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 19.39
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 19.35
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 19.33
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 19.31
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 19.27
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 19.27
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 18.77
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 18.38
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 18.32
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 18.28
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 18.22
FOXD3 is a novel tumor suppressor in lung cancer 18.19
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 18.14
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 18.12
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 18.1
Argonaute proteins couple chromatin silencing to alternative splicing 18.1
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 17.85
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 17.85
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 17.83
Altering cancer transcriptomes using epigenomic inhibitors 17.83
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 17.74
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 17.7
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 17.64
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 17.62
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 17.61
Modeling Familial Cancer with iPSC Approaches 17.61
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 17.55
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 17.54
Role for citron kinase in prostate cancer growth 17.54
Controlling for gene expression changes in transcription factor protein networks. 17.5
RNA sequencing of matched nephrectomy samples [RNA-seq] 17.32
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 17.32
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 17.32
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 17.29
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 17.29
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 17.28
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 17.27
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 17.25
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 17.23
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 17.21
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 17.09
Global analyses of the effect of different cellular contexts on microRNA targeting 17.06
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 17.06
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 16.96
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 16.96
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 16.89
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 16.82
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 16.82
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 16.75
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 16.69
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 16.68
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 16.6
TFAP2C signalling in human fibroblasts 16.51
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 16.26
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 16.25
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 16.19
RNA-seq of young and quiescent MRC-5 human fibroblasts 16.12
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 16.05
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 16.05
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 16.04
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 16.01
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 16.01
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 15.94
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 15.92
Rorc disruption in human FG pancreatic cancer cells 15.87
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 15.75
HNRNPL and its RNA Targets in Prostate Cancer 15.75
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 15.69
CSL 15.62
CSL RNA-Seq on HKC and SCC cell lines 15.62
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 15.52
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 15.47
Entrectinib Resistance in a Neuroblastoma Xenograft Model 15.3
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 15.27
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 15.09
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 15.07
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 15.02
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 14.86
The comparison of high-throughput single-cell RNA-seq methods 14.85
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 14.8
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 14.69
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 14.62
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 14.62
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 14.56
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 14.56
Next generation sequencing of small RNAs isolated from exosomes in human semen 14.55
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 14.52
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 14.5
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 14.5
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 14.48
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 14.41
The cohesin release factor WAPL restricts chromatin loop extension. 14.23
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 14.23
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 14.04
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 14.03
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 14.01
Effect of BMP inhibition or stimulation of primary human keratinocytes 14.01
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 13.98
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 13.98
Non-coding regions are the main source of tumor-specific antigens [human] 13.9
Non-coding regions are the main source of tumor-specific antigens 13.9
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 13.81
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 13.77
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 13.61
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 13.55
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 13.53
Differential gene expression in Jagged1 treated human dental pulp cells. 13.52
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 13.48
Gene expression in PANC1 cells treated with Rakicidin 13.47
Expression data from miR340 overexpressing human A549 cells 13.47
DIGIT regulates endoderm differentiation of human embryonic stem cells 13.29
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 13.29
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 13.28
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 13.24
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 13.2
Ribosomal footprinting of MDA-Parental and MDA-LM2 13.13
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 13.13
Transcriptome of human white and brown adipose tissue biopsies 13.1
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 13.06
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 13.04
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 13.01
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  12.98
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 12.98
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 12.94
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 12.93
Regulation of highly expressed hCINAP on translatome 12.85
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 12.81
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 12.68
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 12.66
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 12.58
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 12.58
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 12.52
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 12.44
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 12.41
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 12.41
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 12.4
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 12.37
RNA sequencing analysis of human embryonic stem cells and axial progenitors 12.36
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 12.36
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 12.32
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 12.32
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 12.3
A transcriptome dataset revealing the molecular features of breast cancer stem cells 12.26
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 12.25
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 12.19
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 12.19
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 12.06
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 12.03
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 11.98
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 11.89
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 11.84
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 11.82
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 11.81
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 11.81
IDH3a KO RNA-seq 11.78
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 11.74
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 11.72
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 11.7
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 11.68
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 11.68
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 11.68
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 11.64
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 11.64
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 11.63
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 11.62
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 11.62
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 11.59
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 11.57
DJ-1 is dispensable for human stem cell homeostasis 11.53
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 11.47
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 11.42
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 11.39
Ribosomal footprinting of CN34-Parental and CN34-LM1a 11.36
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 11.35
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 11.35
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 11.32
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 11.3
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 11.27
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 11.27
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 11.24
Measure transcript integrity using RNA-seq data 11.23
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 11.18
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 11.18
Functional role of SLIT2 and ROBO1 in trophoblasts 11.15
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 11.05
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 11.02
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 11.02
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 11.02
Chromatin-informed inference of transcriptional programs in gynecologic cancers 10.98
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 10.98
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 10.89
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 10.89
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 10.86
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 10.81
Gene expression profiling of KSHV-infected periodontal ligament cells 10.73
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 10.64
TGF-β regulation of miRNA expression in pancreatic cancer 10.61
Exploring the RNA landscape of endothelial exosomes 10.61
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 10.44
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 10.36
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 10.35
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 10.35
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 10.3
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 10.27
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 10.27
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 10.23
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 10.19
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 10.12
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 10.12
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 10.11
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 10.1
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 10.09
RNA seq comparison between scrambled and shGRP78 cells 10.08
Differential gene expression profiles in imatinib-resistant cell lines 10.08
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 10.08
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 9.98
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 9.85
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 9.83
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 9.81
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 9.81
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 9.8
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 9.8
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 9.69
Capturing the Interactome of Newly Transcribed RNA (RICK) 9.69
Capturing the Interactome of Newly Transcribed RNA 9.69
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 9.67
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 9.6
PGE2 mediated gene expression changes in human cervical stromal cells 9.58
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 9.56
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 9.56
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 9.52
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 9.47
Gene expression signatures of innate lymphoid cells from human blood 9.41
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 9.36
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 9.14
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 9.1
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 9.1
Tracing Enhancer Networks using Epigenetic Traits (TENET) 9.02
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 8.96
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 8.92
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 8.85
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 8.55
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 8.47
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 8.47
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 8.37
Analysis of transcriptional regulation by Myt1 and Myt1l 8.37
Searching for target genes of miR-508/509/506/514 in HCT116 cells 8.36
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 8.33
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 8.21
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 8.21
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 8.15
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 8.12
RNA-seq analysis of RALD iPSCs after in vitro differentiation 8.11
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 8.05
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 8.03
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 7.96
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 7.93
Random mono-allelic expression in MECP2-mutated cells 7.82
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 7.81
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 7.61
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 7.59
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 7.52
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 7.47
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 7.42
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 7.42
Gene expression profile in breast cancer cell lines using RNA sequencing 7.42
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 7.26
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 7.26
ARID1A and ARID1B loss in HCT116 cells 7.21
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 7.15
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 7.08
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 6.98
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 6.97
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 6.91
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 6.91
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 6.87
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 6.72
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 6.65
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 6.64
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 6.62
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 6.48
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 6.33
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 6.33
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 6.22
Activity-dependent transcriptional changes in human neurons 6.22
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 6.13
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 5.97
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 5.87
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 5.82
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 5.72
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 5.71
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.6
mRNA differential expression analysis in a human ex vivo model of chronic wounds 5.57
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 5.41
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 5.39
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 5.36
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 5.29
The role of the Calcium-Sensing receptor in colorectal cancer 5.23
Regionally specified human pluripotent stem cell-derived astrocytes 5.2
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 5.17
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 4.98
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 4.91
Characterization of human ILC2 subsets 4.9
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 4.88
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 4.8
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 4.67
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 4.62
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 4.61
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 4.61
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 4.58
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 4.58
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 4.53
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 4.43
Identification of the role of polydom in neurofibromas 4.35
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 4.18
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 4.18
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 4.09
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 4.08
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 4.01
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 3.93
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 3.82
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 3.69
MRTF activates TEAD-YAP target gene expression 3.69
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 3.68
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.67
The transcriptome effect of overexpressing EZH2 in MCF7 3.6
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 3.56
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 3.4
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 3.37
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 3.35
RNA-Seq of Breast and Ovarian Cancer Cell Lines 3.35
RNAseq of Breast cancer PDX samples 3.28
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 3.07
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 3.03
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.0
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 2.95
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 2.95
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 2.87
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 2.77
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 2.71
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 2.69
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 2.68
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 2.6
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 2.42
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 2.41
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 2.37
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 2.3
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.3
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.29
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 2.26
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 2.17
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 1.98
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.92
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.9
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 1.89
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 1.89
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.83
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 1.62
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 1.61
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 1.6
Exogenous rescue of KLHL9 in SF210 cell line 1.53
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 1.46
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.46
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.29
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 1.18
Effects of transcription on genome - nuclear lamina interactions 1.15
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.15
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 1.12
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 1.12
FOXP2's impact on the primate transcriptome 1.12
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 1.12
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.05
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 0.95
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.91
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.91
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.88
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.85
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.84
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.84
Iron response of HepG2 cells 0.78
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.76
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.76
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 0.73
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 0.69
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.69
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 0.61
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.56
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.56
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 0.54
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.54
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.41
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 0.26
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.26
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.23
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.21
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 0.17
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 0.17
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.16
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.07
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 0.05
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.01
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation